论文信息 - Myasthenia Gravis Lambert-Eaton overlap syndrome induced by nivolumab in a metastatic melanoma patient - 字舞流文

Myasthenia Gravis Lambert-Eaton overlap syndrome induced by nivolumab in a metastatic melanoma patient

S. Prey | C. Dutriaux | F. Duval | Antoine Soulages | Alexandra Duplaine | Camille Prot | Gwendal Le-Masson

[1] M. Suarez‐Almazor,et al. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature , 2019, Journal of Immunotherapy for Cancer.

[2] D. Scheie,et al. Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies , 2018, Neurology.

[3] D. Scheie,et al. Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies: Systematic Review , 2018 .

[4] S. Minami,et al. Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer , 2018, Case Reports in Neurology.

[5] Shin J. Oh. Myasthenia gravis Lambert‐Eaton overlap syndrome , 2016, Muscle & nerve.

[6] S. Miller,et al. Epitope spreading in immune-mediated diseases: implications for immunotherapy , 2002, Nature Reviews Immunology.